Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Share:
Related PRGO
Shares Pull Back As Problems Pile Up At Perrigo
Top Performing Industries For September 22, 2016
Related IPXL
Heightened Drug Pricing Scrutiny Now A Factor In Analysts Views Of Impax Labs, Concordia International
Mylan Is Offering An EpiPen Savings Card, But A Lot Of People Will Still Get Screwed

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News

 

Related Articles (IPXL + PRGO)

View Comments and Join the Discussion!